Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects
Alergologia · 2017
DOI: 10.26416/aler.1.1.2017.1240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alergologia, 2017. Verfasst von Polliana Mihaela Leru. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Angiotensin-converting enzyme inhibitors (ACEI) have been largely used in clinical practice for more than 30 years, mainly for treating arterial hypertension and heart failure. They have been proven to reduce cardiovascular risk, by reducing mortality and morbidity after miocardial infarction and stroke . Besides their well known positive effects, treatment with ACEI may induce some adverse reactions, such as chronic cough and angioedema. Intolerance to ACEI is due to increasing levels of bradikinin in plasma and lungs, secondary to blocking the conversion of angiotensin II to angiotensin I. Cough induced or agravated by ACEI is quite frequently encountered in clinical practice and generally underestimated. Angioedema associated with ACEI therapy has a low incidence, but because of the large number of patients treated with this class of medication, ACEI is the most common cause of angioedema in adults who presented to hospitals or emergency departments. Angioedema may occur any time during the ACEI therapy, usually in the first year, but late onset is possible, leading to delayed or confused diagnosis. The reported incidence is higher in women, African-Americans and patients with previous drug allergies. Diagnosis of ACEI induced angioedema may be difficult because of the late onset, clinical picture similar with histamine-induced angioedema and concomitant medication. Bradikinin- mediated angioedema does not respond to standard therapy with antihistamines, corticosteroids and adrenaline, usually used for treating allergic reactions. Recent studies support the usefulness of subcutaneous icatibant, a selective bradikin B2 receptor antagonist.
Zitieren
APA
Leru, P. M. (2017). Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects. Alergologia. https://doi.org/10.26416/aler.1.1.2017.1240
Vancouver
Leru PM. Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects. Alergologia. 2017. doi:10.26416/aler.1.1.2017.1240
BibTeX
@article{Leru2017,
author = {Leru, Polliana Mihaela},
title = {Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects},
journal = {Alergologia},
year = {2017},
doi = {10.26416/aler.1.1.2017.1240}
}
EUVIMED